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Summary  
 
Problems with sleep are reported to be common after stroke but the incidence and prevalence 
of insomnia and insomnia symptoms following stroke is not yet established.  
The aim of this review was to conduct a systematic review and meta-analysis of the incidence 
and prevalence of insomnia and insomnia symptoms in individuals affected by stroke. 
 
We searched seven main electronic databases to identify studies until September 25, 2018.  
 
No studies examining incidence of post-stroke insomnia were identified. Twenty-two studies 
on prevalence of insomnia or insomnia symptoms including individuals with stroke were 
included with fourteen studies suitable for inclusion in the meta-analysis. Meta-analysis 
indicated pooled prevalence of 38.2% (CI 30.1-46.5) with significantly higher prevalence 
estimates for studies using non-diagnostic tools, 40.70% (CI 30.96-50.82) compared to 
studies using diagnostic assessment tools 32.21% (CI 18.5–47.64). Greater insomnia 
symptoms were indicated in those with comorbid depression and anxiety. 
 
The prevalence of both insomnia and insomnia symptoms are considerably higher in stroke 
survivors compared to the general population. Studies investigating the incidence, insomnia 
symptom profile and changes in insomnia prevalence over time are needed to inform clinical 
practice and to encourage tailored interventions that consider this symptomatology. 
 
PROSPERO registration number CRD42017065670. 
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Abbreviations 
BBT-I  Brief Behavioural Treatment-Insomnia  
CBT-I  cognitive behavioural therapy for insomnia 
CI   confidence interval 
CT  computerised tomography 
DFS  Difficulty falling asleep 
DMS  Difficulty maintaining sleep 
DSM  Diagnostic and Statistical Manual of Mental Disorders 
EMA  Early morning awakening 
ICD  International classification of disease 
ICSD  International Classification of Sleep Disorders 
MeSH  Medical subject heading 
MRI  magnetic resonance imaging 
NRS  Non-restorative sleep 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analysis 
PROSPERO International prospective register of systematic reviews 
PSQI  The Pittsburgh Sleep Quality Index 
TIA  Transient ischaemic attack 
 
Stroke 
Stroke is the second leading cause of death [1] and one of the leading causes of disability 
with an increasing prevalence worldwide [2]. Stroke survivors are often left with sequelae of 
long term effects including impairments in mobility, cognition, language and communication, 
as well as emotional problems, difficulties with activities of daily living and social isolation. 
[3-5]. Changes in sleep are commonly reported following stroke but have been less 
extensively researched and receive less attention during rehabilitation despite poor sleep 
being a risk factor for stroke [4, 6] and an independent predictor of life satisfaction six 
months after stroke, alongside depression and stroke severity [6]. 
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Insomnia 
Insomnia is diagnostically defined as difficulty initiating/maintaining sleep, or early-morning 
awakening for at least 3 nights per week over a period of at least 3 months that affects 
daytime functioning [7]. In the general population, insomnia prevalence is relatively low 
(6%) when insomnia is diagnosed using the Diagnostic and Statistical Manual of Mental 
Disorder-IV (DSM-IV) [8]. However, the prevalence insomnia symptoms is considerably 
higher (30–48%) when insomnia is defined based on the core insomnia symptom profile [9]. 
Prevalence of insomnia and insomnia symptoms are estimated to be higher in stroke 
survivors [10]. Current diagnostic systems have moved away from the classification of 
insomnia into primary and secondary insomnia so that insomnia is considered an independent 
disorder and not related to, or an outcome of, another mental or physical disorder [11]. The 
terminology throughout this review will be based on the recent guidelines on the diagnosis 
and treatment of insomnia using the terms insomnia and insomnia disorder interchangeably 
and the concept of comorbidity [11]. 
 
High associations between post-stroke insomnia and depression [12], disability [13] and 
fatigue [10]  have been reported in addition to significant impact on return to work one year 
after stroke [13].  Frequent night time awakenings in the absence of other insomnia 
symptoms also shows an association with suicidal ideation in this group [14]. 
 
A number of reviews have explored the impact of sleep disorders including insomnia as a risk 
factor for stroke [15, 16], or the role of sleep in recovery following stroke [17]. However, no 
published systematic reviews of the prevalence or incidence of insomnia post-stroke exist. In 
an unpublished doctoral thesis, Dixon presented a systematic review of studies examining 
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prevalence of insomnia after stroke [18]. Eleven studies were identified, but methodological 
inconsistencies of the studies included made ascertaining overall insomnia prevalence 
difficult. The aim of this systematic review is to offer a detailed synthesis of the existing 
evidence on the incidence and prevalence of insomnia following stroke. The main question 
this review aims to answer is what is the incidence and prevalence of insomnia and insomnia 
symptoms in individuals following stroke. In order for healthcare professionals and services 
to provide accurate and tailored assessment, advice and interventions on insomnia and 
insomnia symptoms following stroke, we need to develop a better understanding of the 
prevalence of this disorder.  
 
Method 
The review protocol was registered with the International Prospective Register of Systematic 
Reviews (PROSPERO), registration CRD42017065670. Preferred Reporting Items for 
Systematic Reviews and Meta-analysis (PRISMA), [19] was employed to guide study 
selection and reporting. MG, SB and NG performed the database and hand searches. MG and 
SB independently screened titles and abstracts, reviewed full-texts and performed quality 
ratings. Data was extracted by MG, SB, NG and SG.  
 
Literature search  
A concept based search strategy with medical subject headings (MeSH) and keywords 
relating to stroke and insomnia developed in collaboration with a librarian was used to search 
the following electronic databases: MEDLINE (OVID) including ahead of print, In-process 
and other non-indexed citations, EMBASE (OVID), EBSCOhost including CINAHL, 
PsycINFO, PsychARTICLES, Cochrane Library (CENTRAL) and Web of Science to 
identify studies from inception to 20th April 2017 with a further update to September 25, 
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2018. We restricted the searches to studies in humans and publications in English. Details of 
the search strategy are provided in the supplement. The searches were exported to EndNote 
X7.8 and duplicates removed. Titles and abstracts generated from the electronic database 
searches were screened for relevance independently by two reviewers using Rayyan QCRI 
[20]. Irrelevant titles and abstracts were excluded. Potentially eligible full text articles 
identified were obtained and inspected to determine eligibility by the same independent 
reviewers. Any disagreements were resolved by discussion. For full-texts that could not be 
accessed, an attempt to request a copy from the authors directly was made. Titles specific to 
sleep, insomnia and stroke were hand searched.  
 
Inclusion criteria 
We used the following criteria to determine eligibility (further details provided in the 
supplement). Where eligibility could not be determined from the publication directly, an 
attempt to contact the study authors to clarify methodology used was made.   
 
Types of Studies 
We included original full-text articles published in peer-reviewed journals in English. We 
included cohort and cross sectional studies (standalone, or part of a prospective study). We 
excluded case studies or case series (defined as <10 participants).  
 
Population 
We included studies of adult stroke survivors (≥18 years of age) in any location, and any time 
post-stroke. We included studies of people with a clinical diagnosis of stroke (‘rapidly 
developing signs of focal or global disturbance of cerebral functions lasting more than 24 
hours or leading to death’ as defined by the [21] regardless of whether first ever or recurrent, 
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ischemic or haemorrhagic. We also included diagnosis of clinician advised stroke (self-
report), stroke reported on medical reports as well as self-reported strokes. We excluded 
studies reporting transient ischemic attacks (TIA) defined as ‘acute loss of focal cerebral or 
monocular function with symptoms lasting <24 hours and that is thought to be due to 
inadequate cerebral or ocular blood supply as a result of arterial thrombosis or embolism’ 
[22] and sub arachnoid haemorrhage (SAH) defined as a ‘haemorrhage from a cerebral blood 
vessel, aneurysm or vascular malformation into the subarachnoid space (the space 
surrounding the brain where blood vessels lie between the arachnoid and pia mater)[23] due 
to the presentation of SAH usually differing from the presentation of other types of stroke. 
Studies with a “mixed” population (e.g. stroke and TIA), where the results had not been 
reported separately for stroke, were included if the overall stroke sample was more than 80%. 
 
Outcomes 
The primary outcomes were prevalence (number of persons with the condition at a specific 
time point) and incidence (number of new cases of disease in the population, within a year) of 
post-stroke insomnia/insomnia symptoms. Incidence rate was calculated as the number of 
new events in the specific period divided by the number of persons exposed to risk during 
this period. Prevalence was calculated by dividing the total number of all individuals with the 
condition at a particular time with the population at risk of having the condition at this time 
point [24]. 
 
Diagnosis of insomnia was based on any recognised classification or clinical diagnostic 
criteria (e.g. DSM-IV/V, ICSD-2, ICD-10). All other instruments such as questionnaires [e.g. 
Pittsburgh Sleep Quality Index (PSQI), Hamilton Depression Scale (HDS), Epworth 
Sleepiness Scale (ESS)] or self-reported insomnia were classed as insomnia symptoms using 
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author defined cut offs and definitions of insomnia. (Table 3). These symptoms were likely to 
reflect some but not always all of the DSM diagnostic criteria and insomnia symptom 
profileincluding issues with sleep onset, maintenance or early morning awakenings in 
association with feeling rested upon awakening and daytime consequences of poor sleep. We 
included studies using both subjective (e.g. questionnaires) and/or objective measures (e.g. 
actigraphy or polysomnography) as well as studies with self-reported insomnia/insomnia 
symptoms.  
 
Secondary outcomes 
Where available, we collected data on demographic, stroke and sleep related factors and 
comorbidity. 
 
 
Data extraction  
A study specific proforma was created, piloted and refined before data extracted. Extracted 
data included: Citation details (authors, year, title, journal, volume, pages); demographic 
characteristics (age, gender, employment, education, country; study characteristics (numbers 
at baseline and follow up); methods (study design, sampling method, setting, comparison 
group characteristics); stroke characteristics (type, severity, laterality, method of diagnosis, 
recurrence, time since stroke); insomnia/insomnia symptoms (assessment method and 
instrument, definition, incidence, prevalence, pre-stroke sleep quality; comorbidity 
(current/premorbid psychological, psychiatric or physical health problems); funding source 
and conflicts of interest. 
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Study quality  
The methodological quality of the included studies was assessed using the critical appraisal 
tool for prevalence studies [25] with further guidance from Munn et al., [26]. More specifically, 
for the evaluation of valid methods, we split this question into two to cover both methods used 
for the identification of 1. Stroke (Y= stroke confirmed clinically, e.g. WHO classification, and/or 
using imaging, N = self-report, U= assessment method not reported) and 2. Insomnia (Y= use 
of clinical diagnostic tool for insomnia/validated questionnaires ,e.g. PSQI, for insomnia 
symptoms, N= e.g. self-report U= unclear of method and/or its validity). No study was excluded 
based on quality rating but data were synthesised separately for studies using diagnostic and 
non-diagnostic tools.  Any disagreements in quality ratings between reviewers were resolved 
by discussion. 
 
Data analysis 
Our primary approach was to present a narrative review of results, supported by tabulated 
detail of included studies; summary of findings and quality of included studies. We also 
pooled data using meta-analysis techniques. Where the results of the same study were 
reported in multiple publications, we only included the article reporting the largest sample 
size in the data synthesis. We split the included studies by subgroup for analysis in order to 
look at the effect of different diagnostic approaches on prevalence (given that non-diagnostic 
tools are likely to reflect some but not always all of the DSM diagnostic criteria) stroke type, 
severity, geography, quality, study setting. Where available, we described prevalence rates 
separately for different types of stroke, demographic characteristic and insomnia 
comorbidities. 
Meta-analysis was carried out using ‘Metafor’ [27] and ‘Meta’ [28] packages implemented in 
R Statistical Software [29] with random effects (to account for heterogeneity following 
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assessment of the I2 statistic) model and double arcsine transformation. Pooled prevalence 
estimates are reported using 95% confidence intervals (CIs) with the results and 95% CIs 
back-transformed for ease of interpretation.  
 
 
Results 
We identified 2183 records through database searches (2098 through initial search up to 20th 
April 2017, and an additional 85 through updated search up to 25th September 2018) and two 
additional references through other sources (one through initial search and one through 
updated search). After removal of duplicates, 1659 titles and abstracts were screened for 
inclusion and 1480 were excluded leaving 179 for full-text screening. Of these, 157 were 
excluded leaving 22 studies to be included in the data synthesis with 14 studies contributing 
data to the meta-analyses (Figure 1). 
 
Study characteristics 
Characteristics of included studies [6, 10, 12, 13, 30-47] are provided in Table 1.  
 
The identified studies were published between 1996 and 2018. Seventeen studies were cross-
sectional, three longitudinal and two prospective cohort studies of which one was 
longitudinal. These reported data for 75,273 participants of which 19,125 were individuals 
with stroke (sample size n=16–12,045).  
 
Study setting 
Sixteen studies were hospital based (including rehabilitation centres) and six were population 
based covering a wide geographical area: South America (Brazil), n=1; North America 
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(USA), n=2; Europe (UK, Finland, Bosnia/Herzegovina, Italy), n=5, Asia (China, Japan, 
Republic of Korea, Turkey), n=12, Australia, n=1 as well as a multi-country study n=1.  
 
Insomnia assessment 
Six of the twenty-two studies used a diagnostic tool to assess insomnia (Table 2). The DSM 
(IV or V, American Psychiatric Association was used in all alongside other diagnostic tools. 
For studies assessing insomnia symptoms the PSQI [48] was most commonly used, followed 
by sets of questions designed by researchers (Table 3). Eight studies reported insomnia 
subtypes. 
 
Incidence of post-stroke insomnia/insomnia symptoms 
No studies assessing incidence were identified.  
 
Prevalence of post-stroke insomnia/insomnia symptoms using clinical diagnostic tools 
All six studies (n=983 participants) assessing insomnia using a recognised classification or a 
clinical diagnostic criteria (Table 2) used DSM IV/V criteria. In addition, one reported also 
using ICSD-II, one KECA-R and one ICSD-R. The prevalence of insomnia ranged from 
14.8% to 59.8%.  
 
Prevalence of post-stroke insomnia symptoms non-clinical diagnostic tools 
Sixteen studies (n=18,142 participants) assessed insomnia symptoms (Table 3). The 
prevalence of insomnia symptoms, assessed using a variety of questionnaire measures, 
ranged from 19.8% to 69% (to 78% using a lenient definition of sleep disorder). Nine studies  
provided further information on insomnia symptom profile: Difficulties in sleep initiation 
ranged from 28.6-47.8% with the exception of one study reporting prevalence of 6.5% [42]. 
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Difficulties in sleep maintenance varied considerably (14.3%-65.2%) with Li et al, again 
reporting lower prevalence at 4.8% [42]. Early morning awakening ranged from 17-34.1% 
with the exception of Li et al, (4.2%). The rates of non-restorative sleep ranged from 15.4% 
to 52.2%. Two studies reported impacts on daytime consequences (12.6% and ~52%)[12, 33] 
and four reported daytime sleepiness (8.7%-50%) [30, 37, 43, 45]. Only one study assessed 
symptom profile at two different time-points [6] reporting a reduction in prevalence from 
baseline to 18 months across sleep initiation, maintenance and early morning awakenings. 
 
Stroke characteristic 
Stroke type was reported in 13 of the 22 studies. Eight studies included ischemic strokes 
only, four included ischemic and haemorrhagic strokes, and one used another classification 
scheme. Strokes were identified using MRI (n=6), CT (n=2), MRI or CT (n=3) or self-report 
(n=6). Four studies did not provide a detailed account of stroke diagnosis. Time since stroke 
ranged from 3.1 days to 18 months. Nine studies did not report time since stroke. 
 
Impact of stroke characteristics on prevalence of insomnia/insomnia symptoms 
Three studies reported the presence of insomnia/insomnia symptoms by stroke type with no 
significant differences. Stroke severity was reported in three studies, with only one showing 
greater severity in those with insomnia. With regards to lesion location, two studies reported 
no significant differences in sleep disorder and insomnia complaint frequency and one 
reported poor sleep quality being associated with cortical lesions.  
 
Three studies assessed insomnia/insomnia symptoms at multiple time points. One reported 
47% of those with insomnia symptoms at baseline (1 month post-stroke) still having 
insomnia at 6 months with 67% of those at 6 months still having insomnia at 12 months post-
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stroke. By contrast, 21% of those without insomnia at baseline had developed insomnia by 6-
months with 56% of those having insomnia at 6 months still having insomnia at 12 months 
post-stroke [13]. At 14 days post-stroke insomnia prevalence of 46% and 67.7% were 
reported with prevalence of 38.4% at 12-months and 48.9% at 18 months [6, 42].  
 
Demographic characteristics  
Five studies did not report mean age for individuals with stroke, and three only reported age 
range(s) or minimum age for those with stroke. The average age across the remaining 14 
studies was 62.7. Seven studies did not report the gender breakdown. In the 15 remaining 
studies on average, 59.8% were male. Only one study had less than half of the stroke sample 
being male.  
Insomnia/insomnia symptoms preceding stroke  
Only one study assessed pre-stroke insomnia/insomnia complaints prevalence indicating that 
38.6% had pre-stroke onset whereas 18.1% had developed insomnia/insomnia symptoms 
post-stroke. 
 
Impact of comorbidity on prevalence of insomnia/insomnia symptoms 
Depression and anxiety were the most commonly reported insomnia co-morbidities (Tables 2 
and 3). Depression in the presence of insomnia/insomnia symptoms ranged from 24% to 72% 
compared to 9.25% to 25% in those without insomnia symptoms. Similarly, anxiety ranged 
from 30% to 41% in those with insomnia symptoms compared to 9.2% to 15.1% in those 
without. One study reported higher rates of dementia in those with insomnia symptoms 
(24.2%) compared to those without (13.3%). Lower but not significantly different rates of 
cognitive impairment in those with insomnia symptoms were reported compared to those 
without (13% and 19.8% respectively). Other comorbidities reported were hypertension 
Sleep Medicine Reviews  post-stroke insomnia incidence and prevalence 
14 
 
(66.7-75.8% with insomnia symptoms vs. 68.9-70.5% without), diabetes (21.9-40.9% with 
insomnia symptoms vs 21.2%-31.7% without) and previous strokes (20.4% with frequent 
insomnia symptoms vs. 20.5% without).  
 
Study quality 
Quality of the included studies was variable. A summary of quality ratings is provided in 
Table 4. 
Four studies were rated as having the highest possible quality rating. The two areas that 
received the greatest number of low quality ratings were the methods used for the 
identification of stroke and insomnia.  
 
Meta-analyses 
Pooled estimates of prevalence were calculated for 14 studies that included data from 16,894 
individuals with stroke. Studies assessing sleep quality and those reporting prevalence for 
symptom profile only were excluded from the meta-analysis. The overall pooled prevalence 
was 38.2% (CI 30.1-46.5, I2=98%, p<0.01) indicating substantial heterogeneity using a 
random effects model (Figure 2). Publication bias was assessed using a funnel plot (Figure 3) 
followed by the Egger test indicating not significant bias (p = 0.9985). 
 
Prevalence was further analysed by subgroup according to type of assessment tool used 
(clinical diagnostic tools vs. non-diagnostic tools). Two of the studies [10, 33] contributed 
data to both diagnostic and non-diagnostic tool analysis. Subgroup analysis (Figure 4) 
revealed significantly higher pooled prevalence estimates for non-diagnostic tools, 40.70%, 
(CI 30.96-50.82, I2=99%) than for diagnostic tools, 32.21% (CI 18.5-47.64, I2=79%) 
although assessment tool type was not found to have a moderating effect p=0.3645. Further 
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subgroup analyses were considered for stroke type, severity, geography, quality and study 
setting. However these were not feasible due to low number of studies reporting these 
outcomes and/or high between study heterogeneity. 
 
 
Discussion 
There has been a sharp increase in the number of studies investigating the prevalence of post-
stroke insomnia with half of the included studies published since 2015, yet no systematic 
review examining post-stroke insomnia prevalence and incidence has been published to date. 
Six of the twenty-two included studies used diagnostic assessment tools with the remaining 
sixteen using non-diagnostic tools. The quality of the included studies was variable with the 
majority of lower ratings relating to the validity of the methods used to identify insomnia, 
insomnia symptoms and strokes. For example, some population based studies included lower 
than expected number of strokes in the general population which may indicate that only those 
most able participated. 
 
Despite a comprehensive search strategy, no studies assessing the incidence of post-stroke 
insomnia/insomnia symptoms were identified. Leppävuori et al. (2002) reported the 
incidence of new onset insomnia of 18.1% at 3-months post-stroke, however is not a true 
measure of incidence, as it does not account for those who had potentially experienced 
insomnia that had resolved prior to re-assessment at 3-months post-stroke [10]. Glozier et al. 
(2017) reported that 29% (71/244) of those without insomnia at 1-month post-stroke had new 
onset insomnia at 12-months[13]. However, as it is not clear whether those with insomnia at 
baseline (n124) were new onset insomnia, new cases over the following 11-months could be 
only inferred from 66% (n244) of the sample and should be interpreted with caution.  
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The included studies using diagnostic criteria to assess the presence of insomnia following 
stroke highlighted prevalence rates exceeding those of the general population [9] including 
healthy older adults that show prevalence estimates of 15.9-27.6%  with prevalence ranging 
from 14.8% [31] based on DSM-IV-TR criteria to 59.8%, using SCID-P (DSM-IV) [44] with 
a pooled prevalence of 38.15% (CI 30.04-46.60). These rates are comparable to those found 
in post other neuropsychological injuries, such as traumatic brain injury where prevalence for 
insomnia is reported as 29% and insomnia symptomsas 50%[49]. Sleep difficulties and 
insomnia symptoms are likely to increase with age [50], however the prevalence estimates of 
insomnia has not shown to be dissimilar in older adults compared to younger ones [51, 52].  
 
The highest quality study [10] using DSM-IV criteria for insomnia in MRI ascertained stroke 
cases, reported a prevalence of 37.6% for insomnia increasing to 56.7% for insomnia 
complaints. Subgroup analysis of studies of diagnostic tools, revealed a pooled prevalence 
estimate of 32.21% (CI 18.5–47.64).  
 
Drawing on the common characteristics of studies using non-diagnostic tools, such as sleep 
quality (PSQI) and sleep symptoms, the prevalence ranged from 19.8% to 69%. Subgroup 
meta-analysis of studies using non-diagnostic tools, excluding studies with measures of sleep 
quality (e.g. PSQI), excessive daytime sleepiness (e.g. ESS), data for subgroup prevalence 
and secondary time points, revealed a pooled prevalence estimate of 40.7% (CI 30.96–50.82) 
indicating significantly higher prevalence estimates with the use of non-diagnostic tools, a 
pattern also seen in the general population [53]. 
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Included studies exploring insomnia symptom profile such initiation, maintenance and 
daytime consequences in greater detail indicated wide variation in prevalence estimates 
across symptoms. A recent meta-analysis of polysomnography studies [54] indicated poorer 
sleep efficiency, shorter total sleep time, and a tendency for more wake after sleep onset in 
stroke survivors compared to controls. More recently, differences in post-stroke sleep quality, 
latency and duration compared to healthy controls [55] have also been reported. Just one 
study included a control group of healthy adults reporting lower prevalence for sleep onset 
but not for maintenance or restorative sleep [41]. These rates, however, were within symptom 
profile ranges of included studies for stroke reported above. Lower prevalence of difficulties 
in sleep initiation in men and women without a history of stroke was also noted in another 
study with a population based comparator [32].  
 
Three of the included studies reported similar insomnia symptom prevalence for different 
types of stroke [13, 37, 43]. Unlike Palomäki et al. [6] and Tang et al. [46], Li et al. [42] 
found that those with insomnia symptoms had significantly greater stroke severity (NIHSS 
score) than those without. Evidence regarding lesion location was mixed making it difficult to 
ascertain conclusions [6, 43, 45, 56]. Previously, greater sleep disturbance has been reported 
following anterior circulation strokes and frontal lesions [57, 58] compared to posterior 
circulation strokes and left-sided cerebral infarctions [57]. Two studies investigated laterality 
showing no differences [6, 43]. Reviews on stroke laterality and post-stroke depression report 
mixed findings Bhogal et al. 2004 [59] (but see Carson et al. [60] and Wei et al. 2015 [61] 
and warrant further investigation. 
 
Most studies assessed sleep at 1-3 months post-stroke. Low number of studies reporting 
prevalence at multiple time points made it difficult to ascertain how the insomnia status of 
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individual patients had changed over time. Glozier et al. [13] offered a succinct depiction of 
the bidirectional change over time in the onset and maintenance of chronic insomnia. They 
reported cross-sectional prevalence rates of 33.7% at 1-month and 29.9% at 6-months post-
stroke. By contrast, at 6-month assessment point, the prevalence of chronic insomnia (present 
at baseline) was 16% and the remaining 13.9% were instances of acute insomnia. Transition 
to chronic insomnia is a difficult phenomenon to capture [62] with one study employing 
polysomnography analysis indicating that transition may be facilitated by the development of 
depression [63].  
 
Studies using diagnostic tools showed significantly higher prevalence in older participants 
[10, 38] whilst those using non-diagnostic tools [6, 12, 13, 37, 42] did not. This finding 
conflicts with a recent meta-analysis suggesting lower prevalence in older adults and no 
gender differences in prevalence in the Chinese general population [64]. Higher prevalence of 
insomnia and insomnia symptoms were reported in females with the exception of one study 
that reported no significant gender differences in prevalence. A previous meta-analysis has 
indicated that women have 41% greater risk of developing insomnia than men [65].  
 
Less than half of the included studies reported comorbidities relating to post-stroke insomnia. 
Depression and anxiety were most commonly reported ranging from 24%-72% for depression 
and 30-41% for anxiety with all but one study [33] reporting significantly higher prevalence 
or ratings in those with insomnia and/or insomnia symptoms (7) making it difficult to 
disentangle the contribution of comorbidities on post-stroke insomnia. The high rates 
reported for depression are unsurprising given that there is a bidirectional relationship with 
depression, anxiety and insomnia [66, 67]. It has been suggested, that individuals with post-
stroke depressive symptoms are more likely to experience disturbed sleep early post-stroke 
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[68]. This is line with evidence suggesting that over 40% of individuals with insomnia have a 
psychiatric disorder [69] and the argument that sleep disturbances and insomnia may 
facilitate the onset of affective disorders [70]. 
Diabetes is a known risk factor for post-stroke sleep disorders [71]. One study [12] found 
higher rates of diabetes in those reporting insomnia symptoms [12] whilst two other studies 
[42, 46] found no significant difference between groups. Diabetes was also found to be an 
independent predictor of night-time sleep quality [45]. All three studies reporting rates for 
comorbid hypertension with insomnia found no significant differences between those with 
and without insomnia [12, 42, 46].  
Cognitive behavioural therapy for insomnia (CBT-I) is the recommended treatment for 
insomnia [11] with studies showing small to large effects on sleep efficiency, sleep quality 
and sleep onset latency together with reduction in insomnia severity, wake after sleep onset 
and number of awakenings [72]. Suitability or effectiveness of CBT-I post-stroke has only 
been investigated in two small studies (n15, Herron) (n5, Nguyen) reporting improved sleep 
quality, reduction in fatigue, depression and dysfunctional sleep-related beliefs. Improvement 
in sleep efficiency has also been reported post Brief Behavioural Treatment-Insomnia (BBT-
I) using single case methodology in two individuals post-stroke [73]. Given the high 
frequency of cognitive and communication difficulties in this population, tailored stroke-
specific interventions targeting the behavioural components should be further developed. 
Knowledge of post-stroke insomnia prevalence, comorbidities and symptom profiles will 
allow better tailoring of non-medication interventions and addressing comorbidity such as the 
maintenance of insomnia and depression. This is of importance as the side effects of hypnotic 
medications are unclear, especially in relation to neural plasticity and functional recovery 
post injury [74]. Individuals with stroke have a greater risk of hypnotic side effects, including 
cognitive daytime carry over effect, increased risk of falls and issues with polypharmacy due 
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to being older on average [75]. Therefore, whether the benefits of using hypnotic medication 
in this population outweigh the increased risk of adverse events is questionable. The greater 
than population prevalence of insomnia and insomnia symptoms post-stroke indicated by this 
review, highlights the need to assess insomnia in the context of other relevant factors. 
 
Our review is the first to provide a systematic overview of post-stroke insomnia/insomnia 
symptoms prevalence estimates. However, it has some limitations, such as the inclusion of 
articles published in English only. Additionally, study quality was not an exclusion criterion 
and may have contributed to the wide variance in prevalence. Several methodological 
approaches, definitions of insomnia and diagnostic tools were employed to estimate 
prevalence, which also limits the conclusions of the review. It was not possible to conduct a 
meta-analysis of all studies due to not all reporting prevalence at the main group level and the 
heterogeneity of assessment tools used, as many employed bespoke questionnaires. Future 
studies should ensure that sample characteristics are reported for all main and subgroups of 
interest with greater detail provided on stroke and insomnia characteristics including 
comorbidity. Further research should address the instances of insomnia pre-stroke as only one 
study provided details of pre-stroke insomnia and insomnia complaints (38.6%) [10].  
 
Conclusions 
Post-stroke sleep disturbance is disabling and is associated with greater mortality [42] and 
reduced quality of life [56]. This systematic review provides a comprehensive overview of 
the prevalence of insomnia and insomnia symptoms post-stroke, indicating that 
approximately a third of stroke survivors experience insomnia or insomnia symptoms at a 
given time, which is considerably higher than observed in the general population. It also 
highlights the lack of studies examining the incidence of insomnia and insomnia symptoms 
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post-stroke. Research on insomnia after stroke is very much in its infancy and more work is 
needed, especially on tailored psychological interventions such as BT-I and CBT-I.  
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Practice points 
• Post-stroke insomnia is common with approximately a third estimated to meet the 
diagnostic criteria for insomnia, increasing to four in ten for insomnia symptoms only. 
• Routine screening of sleep disorders specifically for insomnia using diagnostic tools 
post-stroke is warranted, particularly in the presence of comorbid depression, anxiety 
or diabetes.  
• Greater attention should be paid to the assessment and monitoring of insomnia and 
insomnia symptoms over time and in treatment context post-stroke.  
 
Research Agenda 
• Studies assessing the incidence of insomnia are currently lacking 
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• Studies should include a measure of pre-stroke insomnia and current insomnia 
symptoms whenever possible. 
• Larger high quality longitudinal studies are needed to assess the progression and 
maintenance of insomnia and insomnia symptoms. 
• In addition to overall prevalence, studies should collect data on stroke characteristics 
(e.g. severity) in order to predict which individuals will be more likely to develop 
insomnia.  
• There is a need to better understand the daytime consequences of insomnia and 
insomnia symptoms over and above the effects of stroke.  
• Insomnia treatment interventions carefully adapted to meet the cognitive, 
communication and neurological needs of this population based on current theoretical 
frameworks (including assessment) and stroke patients’ perspectives are needed, and 
should be evaluated using validated diagnostic-based tools. 
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Figure Legends 
Figure 1 PRISMA flowchart  
 
 
Figure 2. Forest plot of prevalence of insomnia and insomnia symptoms 
 
 
Figure 3. Funnel plot of publication bias 
 
 
Figure 4. Forest plot of the subgroup analysis by assessment tool 
 
 
 
 
 
 
 
1 
 
Table 1. Study characteristics  
Study details Sample characteristics (stroke sample) 
Study  Country Total N (%,  
n of stroke) 
Design Sampling Mean Age, 
years (SD) 
Gender  
%male 
Setting Stroke type  Time since stroke  
(Mean, SD) 
Araujo et al 
201130# 
Brazil 400  
(4% n=16) 
Cross-sectional 
interview 
Consecutive NR NR Haemodialysis 
Centres 
NR NR 
Benbir et al 
201531ǂ* 
Turkey 4,758  
(0.6%, n=27) 
Cross-sectional 
population based 
Survey  
Random 
stratified  
NR NR Population 
based 
NR NR 
Chen et al 
201112#* 
China 508 
(100%) 
Cross-sectional 
interview 
Consecutive 65.7(11.7)  
 
64%  Acute Stroke 
Unit 
Ischemic 100% 
 
3mo 
Glozier et al 
201713#* 
Australia 368 
(100%) 
Prospective 
cohort interview 
Consecutive Range  
18-65  
60%  Hospital  Ischaemic 83% 
Haemorrhagic 13% 
1, 6 and 12mo 
Ito et al. 200032# Japan 518  
(4%, n=21) 
Cross-sectional 
Population based 
survey  
Population-
based health 
examination 
for those 
aged 65 
65 only 66.7%  Population 
based  
NR NR 
Joa et al 
201733ǂ* 
Republic of 
Korea 
208  
(100%) 
Cross sectional 
Cohort self-
administered 
questionnaire 
Multicenter  61.53(12.58) 54%  Hospital Ischaemic 62%  
First ever strokes only 
 
Mild, K-NIHSS 0-5 (41.8%), 
Moderate, K-NIHSS 6-13 
(58.2%), Severe, K-NIHSS 
≥14, excluded 
1mo 
Kalmbach et al 
201634ǂ* 
USA  3,911 
(1.5%, n=57) 
Cross-sectional 
Web-based 
survey 
HMO 
database 
NR NR Population 
based  
NR NR 
Karaca et al 
201635#  
Turkey 23 
(100%) 
Cross-sectional 
questionnaire 
Retrospectiv
e  
60.2(9.9) 
range 46-78 
60.9%  Rehabilitation 
Hospital 
Ischemic 82.6%  
Haemorrhagic 17.4%   
NR 
Kaufmann et al 
201236#* 
USA 
 
 
14,355 
(8.7%, 
n=1,258)  
Population based 
longitudinal 
Survey  
multistage 
probability 
sampling 
with 
clustering 
NR NR Population 
based  
NR NR 
2 
 
Kim et al 
2017a38ǂ* 
Republic of 
Korea 
214 
(100%) 
Cross-sectional 
questionnaire 
NR  60.48(NR) 55.1% Rehabilitation 
centres 
Ischemic 57%  
Haemorrhage 43%  
First ever strokes only 
1mo 
Kim et al 
2017b37#* 
Republic of 
Korea 
241 
(100%), 
includes 36 
TIA (14.9%) 
Cross-sectional 
self-administered 
questionnaire 
Consecutive 64.17(11.89) 
 
 
60.6 %  Hospital  Ischemic 100% 5.4(3.1)d 
Kishimoto et al 
201639# 
Japan 3,732 
(5.8%, 
n=218) 
Cross-sectional 
cohort  
Self-administered 
questionnaire 
and interview  
NR  >65 
 
NR Population 
based  
NR NR 
Koyanagi et al 
201440#* 
Multiple1 42,116 
(28.6%, 
n=12,045) 
Cohort 
interview  
multistage 
clustered 
≥18 years, 
oversamplin
g of age ≥50   
NR General 
population  
NR NR 
Küçükdeveci et 
al 199641#  
UK 46 
(100%) 
47 (non-
stroke 
control) 
Cross-sectional 
interview 
Consecutive 58.3(1.3) 
58.2(1.3) 
non-stroke 
p>0.05 
56.5%  
53.2% 
(non-
stroke) 
p>0.05 
Rehabilitation 
based  
Collected, NR 
 
median 15.9mo 
(range 3.1-38.2) 
but at least 1.5mo 
post-discharge 
Leppävuori et al 
200210ǂ* 
Finland 277 
(100%) 
Cross-sectional 
interview 
Consecutive 70.7(7.5) 
 
50.9%  Hospital  Ischemic 100% 
 
3-4mo 
Li et al 201842#* China 1062 
(100%) 
Longitudinal 
Prospective 
cohort 
Questionnaire  
NR  60.47(11.57) 65.7%  Hospital  Ischemic 81.3%  
First ever strokes only 
14d, 3mo,  
6mo (NR), 12mo 
Palomäki et al 
20036#* 
Finland 100  
(100%) 
Longitudinal 
RCT/Interview 
Consecutive 55.2 (median 
56.0, range 
27–70) 
68 %  
 
Hospital  Ischemic 100% 
  
14d (range 4-30);  
18mo 
Pasic et al 
201143# 
Bosnia and 
Herzegovina 
200 
(100%) 
Cross-sectional 
interview 
Consecutive NR NR Hospital  Haemorrhagic and ischemic 
(breakdown NR) 
NR 
Spalletta et al 
200544ǂ* 
Italy 200 
(100%) 
Cross-Sectional/ 
interviews 
Consecutive  65.7  42%  Hospital  Ischemic 82%  
First ever strokes only  
40.5d (range 3wk-
3m) 
3 
 
1SAGE (China, Ghana, India, Mexico, Russia and South Africa), COURAGE (Finland, Poland and Spain) 
HMO, Health Maintenance Organization; K-NIHSS, Korean version of the National Institute's Health stroke scale; NR, not reported; RCT, Randomised controlled trial; SD, standard deviation; 
TIA, Transient ischemic attack  
* included in meta-analysis 
ǂ Study using diagnostic assessment tool(s) 
# Study using non-diagnostic assessment tool(s) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Suh et al 
201445# 
Republic of 
Korea 
282 
(100%) 
 
 
Cross-sectional 
Interview 
Consecutive 62.34(12.76) 
 
58.9%  Hospital  Large artery disease 37.2% 
Small artery disease 27.7%  
Others 18.4%  
Cardiogenic 16.7% 
6.7(1.89)d 
Tang et al 
201546#* 
China 336 
(100%) 
Cross-sectional 
Self-administered 
questionnaire 
Consecutive 66.1(10.2) 66.4%  Hospital  NR 
 
At least 7d prior 
inclusion 
Yang et al 
201747# 
China 1418 
(100%) 
Cross-sectional 
interview 
Consecutive 61.9(11.3) 66.6%  Hospital  Ischemic 100%  
 
14±2d;  
1y 
4 
 
Table 2. Studies assessing insomnia using clinical diagnostic tools (stroke sample only) 
First Author, 
year 
Insomnia 
Assessmen
t  
Stoke  
Assessment 
Overall prevalence % Insomnia demographic 
characteristics %, mean 
(SD) 
Insomnia 
stroke/clinical 
characteristics 
Insomnia Comorbidity % 
Benbir 
201531 
ICSD-II  
DSM-IV-TR 
Self-report 14.8% insomnia  NR NR NR 
Joa 201733 DSM-IV ICD-10, Brain 
imaging (not 
specified) 
K-NIHSS 
26.9% insomnia  
 
56.7% any sleep disturbance  
43.3% DIS  
47.6% DMS  
33.7% EMA  
40.4% NR  
Approx. 52% DC (detailed data NR) 
NR NR Depression 
Insomnia vs non-insomnia, NS (NR) 
 
Anxiety 
Insomnia vs non-insomnia, NS (NR) 
 
Both significantly correlated with all 
sleep measures 
Kalmbach 
201634 
DSM-V Self-report 36.8% insomnia disorder  NR NR NR 
Kim 2017a34 
 
 
 
 
 
Questionn
aire from 
KECA-R 
used to 
assess 
insomnia 
according 
to DSM-IV.  
MRI and 
neurological 
presentation 
assessment  
59.8% at least 1 of 4 sleep 
complaints over the previous 
month.  
 
Prevalence of specific complaint:  
42.5%, DIS  
46.7%, DMS  
34.1%, EMA  
41.5%, NR   
Age  
Insomnia 62.66 (15.11) 
Non-insomnia 58.29 
(14.06), p=0.034 
 
Gender (%male)   
Insomnia 48.4 %  
Non-insomnia 65.1%, 
p=0.016 
57.8% ischemic  
42.2% 
haemorrhage 
Depression  
Insomnia 59.4%  
Non-insomnia 24.4%, p<0.001  
 
Anxiety  
Insomnia 38.3%  
Non-insomnia16.3%, p=0.001 
Leppävuori 
200210 
DSM-IV MRI 37.6% of all patients/ 
66.2% of all insomniacs fulfilled the 
DSM-IV criteria of insomnia, the 
remaining 53 (19.1%/33.8%) did 
not. 
 
56.7% insomnia complaints 
 
38.6% pre-stroke onset of 
insomnia/insomnia complaints  
Age  
Insomnia 71.6 (7.8) 
Non-insomnia 69.5 (6.8), 
p<0.05 
 
Gender (%male 
Insomnia 45.2%  
Non-insomnia 58.3%, 
p<0.05 
 
Pre-stroke onset 
70.1% Primary  
17.8% Due to 
depression or 
anxiety  
12.1% Due to 
physical illness  
 
Post-stroke onset  
52.0% Primary  
Depression  
51.6% all insomnia, p<0.0001,  
52.0%  new insomnia, p<0.001;  
25.0% non-insomnia.  
Major depression  
34.4% all insomnia, p<0.001,  
34.0%, p<0.01 new insomnia,  
15% non-insomnia. 
 
Anxiety disorder  
5 
 
69.2% fulfilled diagnostic criteria 
for insomnia,  
30.8% criteria for insomnia 
complaints only 
 
Post-stroke insomnia (new 
insomnia) 18.1%  
60.0% fulfilled diagnostic criteria 
for insomnia,  
40.0% insomnia complaints only 
 
 
4.0 % due to 
depression or 
anxiety  
44% due to physical 
illness 
31.2% all insomnia, p<0.0001,  
30.0% new insomnia, p<0.001,  
9.2% of non-insomnia.  
 
Dementia (DSM-III-R)  
24.2% all insomnia, p<0.05,  
38.0% new insomnia, p<0.001  
13.3% non-insomnia  
Spalletta 
200544 
SCID-P for 
DSM-IV  
MRI 43.5% insomnia 
 
NR NR 72% Major Depressive Disorder  
48.4% Minor Depressive Disorder  
23.9% No depressive disorder  
DC, Daytime consequences; DIS, Difficulty in initiating sleep; DMS, Difficulty in maintaining sleep; EMA, Early morning awakening; DSM, Diagnostic and Statistical Manual of Mental Disorders; 
ICD, International classification of disease; ICSD, International Classification of Sleep Disorders; KECA-R, Korean Epidemiologic Catchment Area Study Replication; K-NIHSS, Korean version of 
the National Institute's Health stroke scale; MRI, Magnetic resonance imaging; NR, Nonrestorative sleep; SD, Standard deviation; SCID, Structured clinical interview for DSM-IV patient edition 
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Table 3. Studies assessing Insomnia symptoms 
First 
author, 
year  
Insomnia Symptoms 
Assessment  
Classification Stoke 
Assessm
ent 
Prevalence % Insomnia demographic 
characteristics %, 
mean (SD), 
Age/education (years), 
gender (%male) 
Insomnia 
stroke/clinical 
characteristics (%), 
mean (SD) 
Insomnia Comorbidity % 
significant interactions 
Araujo 
201130 
PSQI  
Berlin questionnaire,  
ESS  
PSQI>5 poor 
sleep quality 
ESS>10  
NR 69% PSQI>5  
50% ESS>10   
NR NR NR 
Chen  
201112 
An insomnia 
questionnaire 
(Chiu et al., 1999) 
Symptoms for the past 1 
month: 
1. On average, how 
many hours do you 
spend asleep 
per night?; 2. How many 
hours of sleep per night 
do you think you need?; 
3. Do you have difficulty 
in falling asleep?; 4. Do 
you have frequent 
wakening in the night?; 
5. Do you wake up very 
early in the morning and 
have difficulty in going 
back to sleep?; 6. Do you 
consider yourself as 
having insomnia?; 7. Do 
you need to take 
sleeping pills at times in 
the past 1 month? If yes, 
how often?; 8. Do you 
Insomnia 
symptoms: 
answer 
‘‘frequent’’ in any 
of questions 3, 4, 
and 5.  
 
DC:answer to 
question 8 ‘yes.’ 
MRI, 
NIHSS 
36.6% insomnia 
symptoms  
 
12.6% DC   
 
 
Age  
FIS 65.5(11.1) 
No FIS 65.8(12.0), 
p>0.05. 
 
Gender 
FIS 61.3%  
No FIS 65.5%, p>0.05  
 
Education 
FIS 5.7(4.7) 
No FIS 5.6(4.6), NS 
 
 
Previous stroke  
FIS 20.4%  
No FIS 20.5%, p>0.05. 
 
Severity (NIHSS on 
admission) 
FIS 4.8(3.5) 
No FIS 4.2(3.3), 
p=0.068 
 
Frontal infarct 
FIS 12.4%  
No FIS 6.8%, p<0.05 
Other brain areas, NS 
 
Cognition (MMSE)  
FIS 26.1(3.2) 
No FIS 26.2(3.2), 
p>0.05. 
Depression (GDS score)  
FIS 5.2(3.3) 
No FIS 3.9(2.8), p< 0.001. 
 
Diabetes  
FIS 40.9%  
No FIS 31.7%, p<0.05. 
 
Hypertension  
FIS 75.8%  
No FIS 70.5%, p>0.05. 
 
COPD  
FIS 6.5%  
No FIS 7.8%, p>0.05. 
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frequently feel tired in 
daytime? 
Glozier 
201713 
Karolinska Sleep 
Questionnaire (modified 
for stroke, assesses 
insomnia for the past 4 
weeks): “Since your 
stroke, 
(1) have you had any 
problems getting to 
sleep?”  
(2) how often have you 
woken too early and not 
been able to get back to 
sleep?”  
(3) how often have you 
been tired or sleepy at 
work or during your 
spare time?”  
Insomnia if 
reported 
problems with 
either of the 2 
nocturnal 
symptoms (sleep 
onset and/or 
early morning 
awakening) 
more frequently 
than 
“often/several 
times per week,” 
in addition to 
reporting daytime 
consequences of 
tiredness or 
sleepiness more 
frequently than 
“often/several 
times per week.” 
Self-
report  
1 month 33.7% 
6 months  29.9%  
12 months 37.0% 
 
Chronic insomnia 
during first 6 months 
16% indicating  
47% still had insomnia 
at 6 months,  
53% had recovered  
 
Of 66% non-insomnia 
at baseline, 79% 
remained good 
sleepers at 6 months, 
of whom 78% 
remained good 
sleepers at 12 months, 
21% had developed 
insomnia by 6 months, 
of whom 56% still had 
insomnia at 12 months 
Age (baseline) 
18-46  
Insomnia 30%  
Non-insomnia 21%  46-
65  
insomnia 70%   
Non-insomnia 79%  
p>0.05. 
 
Gender   
Insomnia 57%  
Non-insomnia 74%, 
p<0.01. 
 
Education 
N.S 
 
Employment 
N.S 
 
Marital status 
N.S 
Stroke subtype 
Ischaemic 84%  
Haemorrhagic 11%, 
p=0.66  
Unknown 5%, p=0.17  
 
Cognitive impairment 
at baseline 
Insomnia symptoms  
13%, Non-insomnia 
symptoms 19.8%, 
p=0.12. 
Depression at baseline  
24% insomnia symptoms 
9.5% non-insomnia 
symptoms, p<0.001 
 
Anxiety at baseline 
41% insomnia symptoms  
15.1% non-insomnia 
symptoms, p<0.001 
 
Ito  
200032 
Insomnia symptom 
questionnaire:  
1.How many hours do 
you sleep at night on an 
average?; 2.How long 
does it take from going 
to bed to falling asleep?; 
3.How many times do 
you usually wake up at 
night?; 4.How do you 
feel when you wake up 
in the morning?  
Sleep disturbance 
DIS: difference 
between bedtime 
and falling asleep 
30min  
 
DMS: awakenings 
more than twice 
 
NR: felt bad in the 
morning. 
Self-
Report 
NR Males vs. 241/497 non-
stroke 
30.8%; DIS (14.5 % 
Non-stroke)  
30.8% DMS (32.2% 
non-stroke)  
15.4% NR (15.4% non-
stroke).  
Any of the 3 
disturbances 66.7% 
(41.7% non-stroke) 
 
NR NR 
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Females vs. 256/497 
non-stroke 
28.6% DIS (22.3% non-
stroke) 
14.3% DMS (28.5% 
non-stroke) 
27.3% NR (18.7% non-
stroke) 
42.9% Any disturbance 
(49.6% non-stroke)  
Karaca 
201635 
PSQI >5=poor sleep 
quality 
NR ≤5=60.9%  
>5=39.1% 
NR NR NR 
Kaufmann 
201236 
 
 
 
 
How often had: trouble 
"falling asleep", "waking 
up during the night", 
"waking up too early and 
not able to fall asleep 
again", and when they 
felt "really rested".  
Categorised as 
having 0,1 or ≥2 
insomnia 
symptoms 
Self-
report 
0=53.2%  
1=21.6%  
≥2 25.2% 
NR NR NR 
Kim  
2017b37 
ISI-K 
PSQI-K 
ESS-K 
ISI-K≥15.5=clinical 
insomnia  
PSQI-K≥8.5=poor 
sleep quality 
ESS-
K≥11=significant 
excessive daytime 
sleepiness 
MRI,  
NIHSS 
mRS-3 
12% Insomnia  
32.8%, PSQI-K  
8.7% ESS-K  
NR 
 
 
Stroke subtype 
NS between Large 
artery 
atherosclerosis, 
Cardioembolism, 
small vessel occlusion 
on ISI-K, PSQI-K, ESS-
K. 
 
Stroke severity  
mRS-3 associated 
with ISI-K, p=0.001 
NR 
 
 
 
 
 
Kishimoto 
201639 
PSQI-Japanese >5.5=sleep 
disturbance 
Self-
report 
46.3% sleep 
disturbance 
NR NR NR 
Koyanagi 
201440 
Overall in the last 30 
days, how much of a 
problem did you have 
Sleep Problems  
none, mild, 
moderate, severe, 
Self-
report 
and/or 
19.8% Severe/extreme 
sleep problems  
Prevalence by country  
China 7.2%, Mexico 
12%, Spain 13.8%, 
NR NR 
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with sleeping, such as 
falling asleep, waking up 
frequently during the 
night or waking up too 
early in the morning?  
extreme/cannot 
do 
with 
symptom
s 
South Africa 18.4%, 
Finland 19.2%, Ghana 
20.8%, Poland 27.5,  
India 31.3%,  
Russia 21.6% 
Küçükdeve
ci 199641 
A four-item sleep 
assessment 
questionnaire 
Higher scores 
indicate higher 
frequency of 
sleep disturbance 
 
Categorised 
according to 
frequency per 
month: Not at all, 
1-3 days, 4+ days 
NR Sleep initiation  
47.8% stroke  
34.0% control  
 
Staying asleep 
65.2% stroke   
59.6% control 
  
Frequent awakening 
39.1% stroke   
46.8% control 
  
Waking up tired 
52.2% stroke   
44.7% control  
NR  NR NR 
Li 201842 HDS insomnia 
symptoms if 
reported 
experiencing: 
▪1≥ sleep 
conditions for at 
least 3 
nights/week; 
▪1≥ sleep 
conditions at two 
consecutive visits.  
CT/MRI 
within 14 
days 
14 days 
46% Insomnia 
6.5% DIS   
4.8% DMS  
4.2% EMA  
4.9% DIS+DMS   
6.9% DIS+EMA 
2.3% DMS+ EMA 
19.8% All three 
complaints   
 
1 year  
38.4% Insomnia 
15.5% One symptom   
33.9% Multiple 
symptoms 
Age  
Insomnia 48.9(46.0) 
Non-insomnia 
57.3(54.0) 
P<0.08, N.S 
 
Gender 
Insomnia 60.1% 
Non-insomnia 70.5% 
P<0.001 
 
Employment  
Insomnia 44.1%  
Non-insomnia 50.4%, 
p=0.04 
Severity (NIHSS)  
Insomnia 5.21(4.38),  
Non-insomnia 
4.12(3.65), p<0.001 
 
Depression (at 1 year) 
54.8% Insomnia  
20.8% Non-insomnia, p<0.001 
 
Diabetes  
21.9%  Insomnia  
21.2% Non-insomnia, p=0.82 
 
Hypertension  
66.7% Insomnia  
68.9% Non-insomnia, p=0.47 
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Pasic 
201143 
Berlin Questionnaire ESS  NR CT scan 78% sleep disorder,  
42% very serious,  
20% moderately 
severe,  
16% medium severe, 
22% no symptoms of 
sleep disorder.  
 
49.5% ESS  
NR  Stroke subtype 
Ischemic 76.8%  
Haemorrhagic 82.5%, 
NS 
 
Lesion location 
33% LHL, 39.5% RHL, 
27% bilateral lesion. 
NS differences in 
Sleep disorder 
frequency  
NR 
Palomäki 
20036 
HDS Insomnia if one or 
more positive 
ratings in any of 
the three sleep 
items in HDS. 
CT or 
MRI 
14 days, 67.7% positive 
for at least 1/3 sleep 
items on HDS: 
41.5% DIS,  
44.1% DMS  
32.3% EMA. 
18 months, 48.9% at 
least one sleep item on 
HDS: 
33.7% DIS,  
23.6% DMS  
17.0% EMA.  
Age 
14 days: young (<56 
years, 66.7%), old (>56, 
68.9%), NS 
18 months: NS,  
p=0.2 
 
Gender  
Men (65.1%), women 
(73.3%), NS 
 
 
Severity  
mild (SSS>47, 69.4%)  
severe stroke (<47, 
65.9%), NS 
 
Lesion location, left 
(63.9%), right 
(70.3%), brain stem 
infarction (70.0%), NS  
 
NR  
Suh  
201445 
Verran–Snyder-Halpern 
(VSH) Sleep Scale 
Higher scores 
indicate better 
sleep quality, 
0(min)-80(max) 
MRI 
within 7 
days  
 
Sleep latency 20min+ 
29.8% 
Increased daytime 
sleepiness  
39.0% 
 
Sleep duration:  
<6h 21.3%,  
6-8h 54.6%,  
8h 24.1%  
 
 
 
 NR Cortical lesions, 
lower VSH Sleep 
Scale score than 
other lesions 
(p=.049). 
 
Subcortical lesions 
(p=.005) and fatigue 
(p<.001) had higher 
increased daytime 
sleepiness 
Depression  
Lower VSH score (p=<.001 
Longer sleep latency (p<.001) 
Greater frequency of waking 
after sleep onset (p=.023) 
 
Diabetes  
Lower VSH score (p=.022) 
 
Fatigue 
Lower VSH score (p=.006). 
Greater frequency of waking 
after sleep onset (p=.010) 
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Hypertension, 
hyperlipidemia, metabolic 
syndrome, and stroke 
subtypes not associated with 
VHS Sleep Scale score 
Tang  
201546 
7-item Insomnia 
Questionnaire derived 
from Chen 2011, 
ESS 
self-reported 
insomnia if 
experienced 1 or 
more days of 
insomnia per 
week in the 
current month  
CT 
 
44% experiencing 
insomnia in the past 
month. 
Age  
Insomnia 66.1(9.7) 
Non-insomnia 
66.0(10.6), p=0.893 
 
Gender 
Insomnia 49.3%  
Non-insomnia 69.5%, 
p<0.01 
 
Education 
Insomnia 6.1(5.0) 
Non-insomnia 6.9(5.0), 
p=0.210 
Severity (NIHSS),  
Insomnia 3.7(3.3) 
Non-insomnia 
3.1(3.3), p=0.137 
 
Previous stroke  
Insomnia 12.2%  
Non-insomnia 9.1%, 
p=0.350 
 
Cognition (MMSE) 
Insomnia 27.5(2.3) 
Non-insomnia 
27.4(2.5), p=0.690 
Depression (GDS score),  
Insomnia 6.2(4.2) 
Non-insomnia 3.1(3.6) 
p<0.01 
 
diabetes  
36.3%insomnia  
30.5%, no insomnia p=0.267 
 
Hypertension 
73.5%,Insomnia  
74.3%, no insomnia p<.859  
 
 
Yang  
201747 
HDS Insomnia if rated 
1 or 2 on at least 
1/3 items. 
MRI or 
CT within 
14 days  
29.0% DIS   
22.4% DMS  
25.4% EMA  
NR NR NR 
CT, computerised tomography; COPD, chronic obstructive pulmonary disease; DC, Daytime consequences; ESS, Epworth Sleepiness Scale (range 0-24); ESS-K, Epworth Sleepiness Scale Korean 
version; FIS, Frequent insomnia symptoms; GDS, Geriatric depression Scale; HDS, Hamilton Depression Scale, items #4(DIS), #5(DMS), #6(EMA); IKI-K, Korean version of Insomnia Severity 
Index; LHL, Left Hemisphere lesion, MMSE, Mini-Mental State Examination; MRI, Magnetic Resonance Imaging; mRS, Modified Rankin Scale; PSQI, Pittsburgh Sleep Quality Index; RHL, Right 
hemisphere lesion; SD, Standard deviation; SSS, Scandinavian Stroke Scale; TIA, transient ischemic attack. 
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Table 4. Study quality  
Study Sample 
frame 
appropriate 
to address 
the target 
population 
Appropriate 
sampling of 
study 
participants 
Adequate 
sample 
size 
Study 
subjects 
and 
setting 
described 
in detail 
Data analysis 
conducted 
with sufficient 
coverage of 
the identified 
sample 
Valid methods 
used for the 
identification 
of insomnia or 
insomnia 
symptoms 
Valid 
methods 
used for the 
identification 
of stroke 
Condition 
measured in 
a standard, 
reliable way 
for all 
participants 
Appropriat
e statistical 
analysis 
Adequate 
response 
rate, if not, 
was low 
response rate 
managed 
appropriately 
Araujo 201130 N Y N Y Y Y Y Y Y Y 
Benbir 201531 Y N N Y N Y N U Y Y 
Chen 201112 Y Y Y Y Y U Y Y Y Y 
Glozier 201713 Y Y Y Y Y Y Y Y Y Y 
Ito 200032 U Y Y Y Y N N Y Y U 
Joa 201733 Y U Y Y Y Y Y Y Y Y 
Kalmbach 201634 Y Y N Y Y N N U Y U 
Karaca 201635 Y Y N N Y Y N U Y U 
Kaufmann 201236 Y Y Y Y Y U N U Y Y 
Kima201738 Y Y Y Y Y Y Y Y Y Y 
Kimb 201737 Y Y Y Y Y Y Y U Y Y 
Kishimoto 201639 N U U Y Y N Y Y Y N 
Koyanagi 201440 Y Y Y U Y N N Y Y Y 
Küçükdeveci 199641 Y Y U U U U U U Y U 
Leppävuori 200210 Y Y Y Y Y Y Y Y Y Y 
Li 201842 Y U Y Y Y Y Y Y Y Y 
Pasic 201143 Y U Y N Y Y Y U N U 
Palomäki 20036 N Y Y Y Y Y Y Y Y Y 
Spalletta 200544 Y Y Y Y Y Y Y Y Y Y 
Suh 201445 Y Y Y Y Y U Y U Y Y 
Tang 201546 Y U Y Y Y Y Y Y Y Y 
Yang 201747 N Y Y Y Y Y Y Y Y U 
Colour code: green, yes; red, no; yellow, unclear 

